Capable of engaging two epitopes or antigens simultaneously, bispecific antibodies (bsAbs) are synthetic proteins that scientists engineer by combining antigen-targeting domains of two monoclonal ...
The oPool+ display platform combines technologies to make and test large numbers of antibodies at once. Illinois researchers analyzed how antibodies bind to the influenza protein hemagglutinin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback